Edition:
United States

Kissei Pharmaceutical Co Ltd (4547.T)

4547.T on Tokyo Stock Exchange

3,070JPY
9:29pm EDT
Change (% chg)

¥20 (+0.66%)
Prev Close
¥3,050
Open
¥3,075
Day's High
¥3,075
Day's Low
¥3,060
Volume
29,900
Avg. Vol
113,347
52-wk High
¥3,130
52-wk Low
¥1,915

Latest Key Developments (Source: Significant Developments)

Vifor Pharma: Kissei to market avacopan in Japan
Friday, 9 Jun 2017 01:24am EDT 

June 9 (Reuters) - VIFOR PHARMA AG ::KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA.  Full Article

R&I affirms Kissei Pharmaceutical's rating at "A-" and says stable outlook – R&I
Tuesday, 7 Feb 2017 01:34am EST 

Kissei Pharmaceutical Co Ltd <4547.T>: Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-" – R&I .Rating outlook stable– R&I.  Full Article

Kyorin and KISSEI sign agreement for co-development and co-marketing of KRP-114V
Wednesday, 30 Mar 2016 02:00am EDT 

Kyorin Holdings Inc:KYORIN Pharmaceutical Co., Ltd., a wholly-owned subsidiary of KYORIN Holdings, Inc. and Kissei Pharmaceutical Co., Ltd. jointly announced a co-development and co-marketing agreement for an overactive bladder medication of KRP-114V (INN: Vibegron) which is being developed by Kyorin in Japan.  Full Article

More From Around the Web

BRIEF-R&I affirms Kissei Pharmaceutical's rating at "A-" and says stable outlook - R&I

* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-" - R&I